Literature DB >> 16325928

Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation.

María de las Mercedes Segura1, Alain Garnier, Amine Kamen.   

Abstract

Sucrose equilibrium density ultracentrifugation remains the most widely used technique for retrovirus purification. However, purified virus preparations obtained by this routine method usually contain considerable amounts of contaminating cell membrane vesicles. In addition, sucrose solutions are highly viscous and hyperosmotic which jeopardizes the integrity and functionality of the retrovirus particle. In order to overcome these limitations, an alternative purification technique using rate zonal ultracentrifugation and iodixanol as gradient medium was developed. Recombinant retrovirus particles were produced by 293-GPG packaging cells grown in suspension in the presence of 10% FBS. Concentrated supernatants were purified by rate zonal sedimentation on a 10-30% continuous iodixanol gradient. Virus particles were recovered intact and active from the central fractions of the gradient. By using this strategy, high levels of purification were achieved, with no evident contamination with cell membrane vesicles as indicated by subtilisin treatment studies. The level of purity of the retrovirus preparation is over 95% as shown by SDS-PAGE analysis and size-exclusion chromatography. Purified particles appear homogenous in size and morphology according to negative stain electron microscopy. In addition, large amounts of defective retrovirus particles produced by 293-GPG packaging cells can be separated from functional retrovirus particles using this purification strategy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325928     DOI: 10.1016/j.jviromet.2005.10.030

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations.

Authors:  María Mercedes Segura; Alain Garnier; Marcos Rafael Di Falco; Gavin Whissell; Angélica Meneses-Acosta; Normand Arcand; Amine Kamen
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

2.  Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.

Authors:  J C M van der Loo; W P Swaney; E Grassman; A Terwilliger; T Higashimoto; A Schambach; C Baum; A J Thrasher; D A Williams; D L Nordling; L Reeves; P Malik
Journal:  Gene Ther       Date:  2011-07-14       Impact factor: 5.250

3.  Purification of Bionanoparticles.

Authors:  L Pedro; S S Soares; G N M Ferreira
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

Review 4.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

Review 5.  Lentiviral Vector Bioprocessing.

Authors:  Christopher Perry; Andrea C M E Rayat
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

6.  Purification of human respiratory syncytial virus by ultracentrifugation in iodixanol density gradient.

Authors:  E Gias; S U Nielsen; L A F Morgan; G L Toms
Journal:  J Virol Methods       Date:  2007-10-29       Impact factor: 2.014

Review 7.  Production of lentiviral vectors.

Authors:  Otto-Wilhelm Merten; Matthias Hebben; Chiara Bovolenta
Journal:  Mol Ther Methods Clin Dev       Date:  2016-04-13       Impact factor: 6.698

Review 8.  Analogies Between Cancer-Derived Extracellular Vesicles and Enveloped Viruses with an Emphasis on Human Breast Cancer.

Authors:  Toni M Green; Mark F Santos; Sanford H Barsky; Germana Rappa; Aurelio Lorico
Journal:  Curr Pathobiol Rep       Date:  2016-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.